• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10373
Medical Device Problem Codes Material Integrity Problem (2978); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/10/2018
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that there was a defect in the access sheath: a left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 33mm watchman laa closure device & delivery system (wds) were used.The closure device was being placed in the laa, but it was not seated properly so the physicians chose to recapture the device.As the device was being recaptured a defect was noted in the tip of the sheath.The was removed and exchanged for a new was.When the access sheath was looked at it was noted that the soft tip had frayed apart.There were no patient complications and a new 33mm wds and a new was were used to successfully implant and release the closure device in the laa.
 
Event or Problem Description
It was reported that there was a defect in the access sheath: a left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 33mm watchman laa closure device & delivery system (wds) were used.The closure device was being placed in the laa, but it was not seated properly so the physicians chose to recapture the device.As the device was being recaptured a defect was noted in the tip of the sheath.The was removed and exchanged for a new was.When the access sheath was looked at it was noted that the soft tip had frayed apart.There were no patient complications and a new 33mm wds and a new was were used to successfully implant and release the closure device in the laa.Device evaluated by mfr: the returned product consisted of the watchman access system (was).The device was bloody.The hub, sheath, and tip were microscopically and visually inspected.Inspection revealed tip damage (partial separation but all of tip was with the device) and numerous kinks in the sheath.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN ACCESS SYSTEM
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8024272
Report Number2134265-2018-62455
Device Sequence Number13751736
Product Code NGV
UDI-Device Identifier08714729838197
UDI-Public08714729838197
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/25/2021
Device Model Number10373
Device Catalogue Number10373
Device Lot Number0022301195
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/19/2018
Initial Date Received by Manufacturer 10/10/2018
Supplement Date Received by Manufacturer11/02/2018
Initial Report FDA Received Date10/31/2018
Supplement Report FDA Received Date11/29/2018
Patient Sequence Number1
-
-